4.0
2 Dec 2022
Current employee, more than 3 years
Tarrytown, NY
Recommend
CEO approval
Business outlook
Pros
High quality science in most areas, aiming to address diseases where the is great need. Employees are paid and treated well.
Cons
Losing the spirit of a biotech and feeling more like big pharma in some areas. Decision making and hiring often driven by VP-level folks in domains where they lack expertise (instead of the actual scientists). Lots of meetings. Too many managers.